These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

905 related items for PubMed ID: 26318557

  • 21. Discovery of Mycobacterium tuberculosis α-1,4-glucan branching enzyme (GlgB) inhibitors by structure- and ligand-based virtual screening.
    Dkhar HK, Gopalsamy A, Loharch S, Kaur A, Bhutani I, Saminathan K, Bhagyaraj E, Chandra V, Swaminathan K, Agrawal P, Parkesh R, Gupta P.
    J Biol Chem; 2015 Jan 02; 290(1):76-89. PubMed ID: 25384979
    [Abstract] [Full Text] [Related]

  • 22. Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis.
    Devi PB, Sridevi JP, Kakan SS, Saxena S, Jeankumar VU, Soni V, Anantaraju HS, Yogeeswari P, Sriram D.
    Tuberculosis (Edinb); 2015 Dec 02; 95(6):786-794. PubMed ID: 26299907
    [Abstract] [Full Text] [Related]

  • 23. A web server for predicting inhibitors against bacterial target GlmU protein.
    Singla D, Anurag M, Dash D, Raghava GP.
    BMC Pharmacol; 2011 Jul 06; 11():5. PubMed ID: 21733180
    [Abstract] [Full Text] [Related]

  • 24. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
    Rajput VS, Mehra R, Kumar S, Nargotra A, Singh PP, Khan IA.
    Appl Microbiol Biotechnol; 2016 Jun 06; 100(12):5415-26. PubMed ID: 26887318
    [Abstract] [Full Text] [Related]

  • 25. Substrate-bound crystal structures reveal features unique to Mycobacterium tuberculosis N-acetyl-glucosamine 1-phosphate uridyltransferase and a catalytic mechanism for acetyl transfer.
    Jagtap PK, Soni V, Vithani N, Jhingan GD, Bais VS, Nandicoori VK, Prakash B.
    J Biol Chem; 2012 Nov 16; 287(47):39524-37. PubMed ID: 22969087
    [Abstract] [Full Text] [Related]

  • 26. Structure-based virtual screening as a tool for the identification of novel inhibitors against Mycobacterium tuberculosis 3-dehydroquinate dehydratase.
    Petersen GO, Saxena S, Renuka J, Soni V, Yogeeswari P, Santos DS, Bizarro CV, Sriram D.
    J Mol Graph Model; 2015 Jul 16; 60():124-31. PubMed ID: 26043661
    [Abstract] [Full Text] [Related]

  • 27. Kinetic modelling of GlmU reactions - prioritization of reaction for therapeutic application.
    Singh VK, Das K, Seshadri K.
    PLoS One; 2012 Jul 16; 7(8):e43969. PubMed ID: 22952829
    [Abstract] [Full Text] [Related]

  • 28. Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
    Doğan H, Doğan ŞD, Gündüz MG, Krishna VS, Lherbet C, Sriram D, Şahin O, Sarıpınar E.
    Eur J Med Chem; 2020 Feb 15; 188():112035. PubMed ID: 31951850
    [Abstract] [Full Text] [Related]

  • 29. Development of potent chemical antituberculosis agents targeting Mycobacterium tuberculosis acetohydroxyacid synthase.
    Jung IP, Ha NR, Lee SC, Ryoo SW, Yoon MY.
    Int J Antimicrob Agents; 2016 Sep 15; 48(3):247-58. PubMed ID: 27451857
    [Abstract] [Full Text] [Related]

  • 30. Discovery of potent antimycobacterial agents targeting lumazine synthase (RibH) of Mycobacterium tuberculosis.
    Singh M, Dhanwal A, Verma A, Augustin L, Kumari N, Chakraborti S, Agarwal N, Sriram D, Dey RJ.
    Sci Rep; 2024 May 28; 14(1):12170. PubMed ID: 38806590
    [Abstract] [Full Text] [Related]

  • 31. High throughput screen identifies small molecule inhibitors specific for Mycobacterium tuberculosis phosphoserine phosphatase.
    Arora G, Tiwari P, Mandal RS, Gupta A, Sharma D, Saha S, Singh R.
    J Biol Chem; 2014 Sep 05; 289(36):25149-65. PubMed ID: 25037224
    [Abstract] [Full Text] [Related]

  • 32. Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.
    Williams JT, Haiderer ER, Coulson GB, Conner KN, Ellsworth E, Chen C, Alvarez-Cabrera N, Li W, Jackson M, Dick T, Abramovitch RB.
    Antimicrob Agents Chemother; 2019 Oct 05; 63(10):. PubMed ID: 31405862
    [Abstract] [Full Text] [Related]

  • 33. The bifunctional protein GlmU is a key factor in biofilm formation induced by alkylating stress in Mycobacterium smegmatis.
    Di Somma A, Caterino M, Soni V, Agarwal M, di Pasquale P, Zanetti S, Molicotti P, Cannas S, Nandicoori VK, Duilio A.
    Res Microbiol; 2019 Oct 05; 170(4-5):171-181. PubMed ID: 30953691
    [Abstract] [Full Text] [Related]

  • 34. Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.
    Matviiuk T, Rodriguez F, Saffon N, Mallet-Ladeira S, Gorichko M, de Jesus Lopes Ribeiro AL, Pasca MR, Lherbet C, Voitenko Z, Baltas M.
    Eur J Med Chem; 2013 Oct 05; 70():37-48. PubMed ID: 24140915
    [Abstract] [Full Text] [Related]

  • 35. Structure of N-acetylglucosamine-1-phosphate uridyltransferase (GlmU) from Mycobacterium tuberculosis in a cubic space group.
    Verma SK, Jaiswal M, Kumar N, Parikh A, Nandicoori VK, Prakash B.
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 May 01; 65(Pt 5):435-9. PubMed ID: 19407371
    [Abstract] [Full Text] [Related]

  • 36. Structure and function of GlmU from Mycobacterium tuberculosis.
    Zhang Z, Bulloch EM, Bunker RD, Baker EN, Squire CJ.
    Acta Crystallogr D Biol Crystallogr; 2009 Mar 01; 65(Pt 3):275-83. PubMed ID: 19237750
    [Abstract] [Full Text] [Related]

  • 37. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
    Baig IA, Moon JY, Lee SC, Ryoo SW, Yoon MY.
    Biochim Biophys Acta; 2015 Oct 01; 1854(10 Pt A):1338-50. PubMed ID: 25988243
    [Abstract] [Full Text] [Related]

  • 38. High-throughput screening identifies novel inhibitors of the acetyltransferase activity of Escherichia coli GlmU.
    Pereira MP, Blanchard JE, Murphy C, Roderick SL, Brown ED.
    Antimicrob Agents Chemother; 2009 Jun 01; 53(6):2306-11. PubMed ID: 19349513
    [Abstract] [Full Text] [Related]

  • 39. Andrographolide: A potent antituberculosis compound that targets Aminoglycoside 2'-N-acetyltransferase in Mycobacterium tuberculosis.
    Prabu A, Hassan S, Prabuseenivasan, Shainaba AS, Hanna LE, Kumar V.
    J Mol Graph Model; 2015 Sep 01; 61():133-40. PubMed ID: 26245695
    [Abstract] [Full Text] [Related]

  • 40. Exploring MDR-TB Inhibitory Potential of 4-Aminoquinazolines as Mycobacterium tuberculosis N-Acetylglucosamine-1-Phosphate Uridyltransferase (GlmUMTB ) Inhibitors.
    Patel HM, Palkar M, Karpoormath R.
    Chem Biodivers; 2020 Aug 01; 17(8):e2000237. PubMed ID: 32469443
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 46.